HAEMOPHILUS INFLUENZA TYPE B

Clinical trials for HAEMOPHILUS INFLUENZA TYPE B explained in plain language.

Never miss a new study

Get alerted when new HAEMOPHILUS INFLUENZA TYPE B trials appear

Sign up with your email to follow new studies for HAEMOPHILUS INFLUENZA TYPE B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New infant vaccine tested to fight serious bacterial infection

⭐️ VACCINE ⭐️ Completed

This study tested a new vaccine called MT-2301 to protect healthy infants from Haemophilus influenzae type b (Hib), a bacteria that can cause serious infections like meningitis. The study involved 154 infants between 2 and 7 months old and compared the new vaccine to an existing …

Matched conditions: HAEMOPHILUS INFLUENZA TYPE B

Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 30, 2026 14:32 UTC

HAEMOPHILUS INFLUENZA TYPE B

Get alerted when new HAEMOPHILUS INFLUENZA TYPE B trials appear

New infant vaccine tested to fight serious bacterial infection